ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $46,518,272 | -12.9% | 1,626,513 | -6.8% | 0.04% | -11.8% |
Q4 2023 | $53,407,466 | +30.0% | 1,745,342 | +14.2% | 0.05% | +21.4% |
Q3 2023 | $41,075,576 | -19.5% | 1,528,678 | +6.9% | 0.04% | -16.0% |
Q2 2023 | $51,014,019 | +44.8% | 1,430,567 | +3.1% | 0.05% | +38.9% |
Q1 2023 | $35,231,983 | -35.1% | 1,387,086 | +3.6% | 0.04% | -37.9% |
Q4 2022 | $54,290,208 | +28.0% | 1,338,516 | +4.3% | 0.06% | +23.4% |
Q3 2022 | $42,398,000 | -6.2% | 1,282,865 | -0.0% | 0.05% | 0.0% |
Q2 2022 | $45,177,000 | -23.0% | 1,283,070 | +0.6% | 0.05% | -6.0% |
Q1 2022 | $58,663,000 | -29.9% | 1,275,556 | +1.0% | 0.05% | +13.6% |
Q4 2021 | $83,734,000 | -7.4% | 1,262,962 | -12.8% | 0.04% | -12.0% |
Q3 2021 | $90,431,000 | -21.6% | 1,448,514 | +4.0% | 0.05% | -18.0% |
Q2 2021 | $115,301,000 | +16.7% | 1,392,194 | -6.5% | 0.06% | +19.6% |
Q1 2021 | $98,783,000 | -15.5% | 1,489,716 | -2.2% | 0.05% | -10.5% |
Q4 2020 | $116,910,000 | +85.3% | 1,523,647 | +4.0% | 0.06% | +46.2% |
Q3 2020 | $63,093,000 | +6.7% | 1,465,242 | +7.0% | 0.04% | -7.1% |
Q2 2020 | $59,117,000 | +153.4% | 1,368,767 | +68.8% | 0.04% | +110.0% |
Q1 2020 | $23,330,000 | -3.5% | 810,892 | +112.7% | 0.02% | +11.1% |
Q4 2019 | $24,182,000 | +729.6% | 381,224 | +268.4% | 0.02% | +800.0% |
Q3 2019 | $2,915,000 | +32.1% | 103,492 | +24.3% | 0.00% | 0.0% |
Q2 2019 | $2,206,000 | -59.8% | 83,233 | -72.2% | 0.00% | -60.0% |
Q1 2019 | $5,492,000 | +28.5% | 299,265 | -13.0% | 0.01% | +25.0% |
Q4 2018 | $4,275,000 | +169.5% | 344,163 | +316.0% | 0.00% | +300.0% |
Q3 2018 | $1,586,000 | +62.2% | 82,739 | +15.1% | 0.00% | 0.0% |
Q2 2018 | $978,000 | +629.9% | 71,896 | +97.0% | 0.00% | – |
Q4 2017 | $134,000 | +16.5% | 36,489 | -41.0% | 0.00% | – |
Q1 2017 | $115,000 | -30.3% | 61,803 | -41.7% | 0.00% | – |
Q4 2016 | $165,000 | -86.1% | 105,984 | -34.4% | 0.00% | -100.0% |
Q3 2016 | $1,190,000 | +50.6% | 161,640 | +8.9% | 0.00% | 0.0% |
Q2 2016 | $790,000 | – | 148,481 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |